Literature DB >> 23386779

Hepatic effects of ketamine administration for 2 weeks in rats.

Y Kalkan1, Y Tomak, D Altuner, L Tumkaya, H Bostan, A Yilmaz, D Unal, A Kara, A Turan.   

Abstract

The aim of the present study was to investigate the long-term and high-dose application of ketamine on the liver by employing histologic and biochemical methods. A total of 30 male rats were randomly assigned to control and four treatment groups (n: 6). Saline for control group and different doses of ketamine for four treatment groups (40, 60, 80 and 100 mg kg⁻¹) were administered intraperitoneal twice a day for 2 weeks. Immunohistological staining, light and electron microscopy were used to study tissue specimens. Histopathological changes were more severe and diverse in groups 80 and 100 mg kg⁻¹ day⁻¹, and the least significant change was observed in groups 40 and 60 mg kg⁻¹ day⁻¹. The most important ultrastructural changes were seen in mitochondria and in the rough endoplasmic reticulum. The immunoreactivity of calcineurin was determined as different. Prolonged use of ketamine caused hepatocellualar toxicity and histological changes in hepatocytes in a dose-dependent manner in all experimental groups.

Entities:  

Keywords:  Hepatotoxicity; ketamine

Mesh:

Substances:

Year:  2013        PMID: 23386779     DOI: 10.1177/0960327112472990

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  9 in total

1.  Binge and Subchronic Exposure to Ketamine Promote Memory Impairments and Damages in the Hippocampus and Peripheral Tissues in Rats: Gallic Acid Protective Effects.

Authors:  G F Brum; H Z Rosa; D R Rossato; J L O Rosa; V G Metz; L H Milanesi; M E Burger
Journal:  Neurotox Res       Date:  2020-05-26       Impact factor: 3.911

2.  Downregulation of the NLRP3/Caspse-1 Pathway Ameliorates Ketamine-Induced Liver Injury and Inflammation in Developing Rats.

Authors:  Xinzhang Chen; Zhiheng Zhang; Meilun Shen; Xiangying Ma; Di Qiu; Siyao Li; Li Gao
Journal:  Molecules       Date:  2022-05-04       Impact factor: 4.927

3.  Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease.

Authors:  Saurav Singh; Alexander Grabner; Christopher Yanucil; Karla Schramm; Brian Czaya; Stefanie Krick; Mark J Czaja; Rene Bartz; Reimar Abraham; Giovana S Di Marco; Marcus Brand; Myles Wolf; Christian Faul
Journal:  Kidney Int       Date:  2016-07-22       Impact factor: 10.612

4.  Ketamine enhances autophagy and endoplasmic reticulum stress in rats and SV-HUC-1 cells via activating IRE1-TRAF2-ASK1-JNK pathway.

Authors:  Yanming Yu; Daoxu Wu; Yongwei Li; Hui Qiao; Zhengfei Shan
Journal:  Cell Cycle       Date:  2021-08-24       Impact factor: 5.173

5.  Environmental enrichment and abstinence attenuate ketamine-induced cardiac and renal toxicity.

Authors:  Xingxing Li; Shuangyan Li; Wenhui Zheng; Jian Pan; Kunyu Huang; Rong Chen; Tonghe Pan; Guorong Liao; Zhongming Chen; Dongsheng Zhou; Wenwen Shen; Wenhua Zhou; Yu Liu
Journal:  Sci Rep       Date:  2015-06-26       Impact factor: 4.379

6.  Multimodal imaging reveals transient liver metabolic disturbance and sinusoidal circulation obstruction after a single administration of ketamine/xylazine mixture.

Authors:  Fang-Hsin Chen; Ching-Fang Yu; Chung-Lin Yang; Yu-Chun Lin; Gigin Lin; Chun-Chieh Wang; Huang-Ping Yu; Jui Fang; Ning-Fang Chang; Ji-Hong Hong
Journal:  Sci Rep       Date:  2020-02-27       Impact factor: 4.379

Review 7.  Prevention and Management of Common Adverse Effects of Ketamine and Esketamine in Patients with Mood Disorders.

Authors:  Felicia Ceban; Joshua D Rosenblat; Kevin Kratiuk; Yena Lee; Nelson B Rodrigues; Hartej Gill; Mehala Subramaniapillai; Flora Nasri; Leanna M W Lui; Orly Lipsitz; Anil Kumar; Jung Goo Lee; Edmond H Chau; Bing Cao; Kangguang Lin; Roger C Ho; Rodrigo B Mansur; Jennifer Swainson; Roger S McIntyre
Journal:  CNS Drugs       Date:  2021-08-07       Impact factor: 5.749

8.  The Risk of Upper Urinary Tract Involvement in Patients With Ketamine-Associated Uropathy.

Authors:  Chi-Hang Yee; Jeremy Yuen-Chun Teoh; Pui-Tak Lai; Vivian Yee-Fong Leung; Winnie Chiu-Wing Chu; Wai-Man Lee; Yuk-Him Tam; Chi-Fai Ng
Journal:  Int Neurourol J       Date:  2017-06-21       Impact factor: 2.835

9.  Ketamine induces endoplasmic reticulum stress in rats and SV-HUC-1 human uroepithelial cells by activating NLRP3/TXNIP aix.

Authors:  Lingjuan Cui; Xiaoyan Jiang; Chengjun Zhang; Danxia Li; Shengqiang Yu; Fengchun Wan; Yue Ma; Wei Guo; Zhengfei Shan
Journal:  Biosci Rep       Date:  2019-10-30       Impact factor: 3.840

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.